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Fatigue is a major symptom among patients with Hepatitis B virus (HBV). However, the physiological 
mechanisms regarding mediate fatigue and the relationships between fatigue, cortisol and cytokines 
are unclear in patients with HBV. The purpose of this study was to examine the relationships between 
perceived fatigue, cortisol, and cytokines in Korean patients with HBV. The mean score for overall 
fatigue was moderate. In linear regression analyses, TNF-α was only significant as a predictor of fatigue. 
In quantile regression analyses, the cortisol level was significant in the 70th, 80th, 90th quantiles in the 
cognitive/mood fatigue subdimension, which correspond to severe levels of fatigue. IL-6 levels were 
significant in 90th quantile in overall fatigue and in the cognitive/mood fatigue subdimension. Cortisol, 
IL-6, and TNF- α were related to perceived fatigue in patients with HBV, particularly in the cognitive/
mood dimension. This suggests that the fatigue patterns of patients with HBV are related to their 
mental and mood states and physical responses, such as cortisol and cytokine levels, are correlated with 
the nature of the fatigue. In the clinic, interventions to manage fatigue in patients with HBV should be 
developed based on the characteristics of the fatigue.
Fatigue is the most frequently reported symptom among patients with hepatitis B virus (HBV) in clinical settings 
and negatively effects on their health outcomes1–3. Fatigue in liver disease is known as central fatigue. Central 
fatigue dose not correlated with traditional marker of disease activity or severity. The diagnosis of chronic liver 
disease includes diverse interaction such as biological, psychological and behavioral process and these can affect 
the clinical expression of fatigue. Fatigue in patients with liver disease has been assessed using perceived fatigue 
questionnaires4.
However, there have been few studies in HBV patients that have evaluated fatigue as it relates to physical 
changes in the body as can be measured by biomarkers. There has been particularly little research done relating 
to the interpretation of fatigue as a physical problem in patients with liver disease except for a study performed 
in liver transplant candidates5. In other chronic diseases where fatigue is the main symptom, it is recognized as a 
physical symptom of the patient and is explained through biomarkers. It is known that cortisol and cytokines are 
representative biomarkers related to fatigue. Several previous studies have attempted to identify the relationship 
between fatigue and various biomarkers in a variety of chronic illnesses. Previous studies have mainly evaluated 
IL-6 and TNF-α in cytokine analyses. TNF-α has not been shown to be related to fatigue, while IL-6 and cortisol 
have been reported to be positively related with fatigue6–11.
Meanwhile, several studies have used ordinary least squares (OLS) regression to determine the relationship 
between biomarkers and fatigue. However, use of the OLS method has potential limitations with respect to the 
interpretation and application of results. Since the OLS regression assumes a normal distribution of the data, the 
results provide information only on the mean of the dependent variable relative to the independent variable12,13. 
The level of fatigue in patients varies greatly in frequency and intensity, but the results of OLS only explain the 
data based on mean values. Therefore, the use of the OLS method to analyze fatigue has a weakness as it does not 
fully represent patients with high-level fatigue in whom intervention is deemed most necessary.
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Quantile regression can be used as an alternative to OLS under the characteristics of these data12. The quantile 
regression method as a robust statistical methodology provides data on the relationship with outliers of predictor 
variables. The application of the quantile regression method to analyze fatigue is useful and suitable for interpret-
ing the results of data with a non-normal distribution12,14. Therefore, the purpose of this study was to examine 
the relationships between fatigue, cortisol, and cytokines in patients with HBV, and compare the results using the 
OLS regression and quantile regression methods.
Results
Demographic Characteristics. The demographic characteristics of the participants in this study are pre-
sented in Table 1. The sample included a total of 143 patients (men 61%, women 39%). The mean of age was 
48.9 years (SD = 11.7) and the average length of diagnosis was 15.3 years (SD = 9.5). Additionally, over 70% 
of the participants had taken antiviral medication. The mean levels of AST and ALT were 29.7(SD = 19.1) and 
29.8(SD = 25.6) respectively. There were no significant differences in fatigue level by comorbidity (t = −1.826, 
p = 0.070), sex (t = −1.499, p = 0.136), taking anti-viral medication (t = 0.083, p = 0.934), and occupation 
(F = 0.977, p = 0.379).
Severity of Fatigue. The mean score for fatigue in this sample was 4.3(SD 1.6), which correlates to a mod-
erate level of fatigue. With respect to the mean scores of the four sub-dimensions, the Sensory subdimension was 
highest (4.58 ± 1.81) and Cognitive/Mood was lowest (3.70 ± 1.95).
Differences of Cortisol and Cytokines by Fatigue Groups. The results for cortisol and cytokines in 
each fatigue group (mild-moderate-severe) are presented in Table 2. The overall mean cortisol level of partici-
pants was 10.04 ± 4.52 μg/ml (range: 2.26~22.19), that of IL-6 was 2.15 ± 1.89 pg/ml (range: 0.08~9.51) and the 
overall mean level of TNF-α was 1.26 ± 1.31 pg/ml (range: 0.21~13.60). The mean value for cortisol in the mild 
fatigue group was higher than those of the moderate and severe fatigue groups. The mean levels of IL-6 and 
TNF-α in the mild group were lower than those of either the moderate or severe groups. However, there were no 
significant differences between the mean values for cortisol and cytokines between the fatigue groups. In addi-
tion, there were no significant differences in fatigue (t = 0.083, p = 0.934), Cortisol (t = −1.090, p = 0.277), IL-6 
(t = 1.422, p = 0.157), and TNF-α (t = 0.614, p = 0.540) by taking anti-viral medication.
N (%) or Mean(SD)
Sex
    Men 86 (60)
    Women 57 (40)
Age 48.9 (11.7)
Living with spouse
    Yes 118 (82.5)
    No 25 (17.5)
Occupation
    Full-time 76 (53.1)
    Part time 3 (2.1)
    Not employed 64 (44.8)
HBV DNA
    <2,000 IU/ml 97 (67.8)
    ≥2,000 IU/ml 46 (32.2)
Length of Diagnosis (years) 15.3 (9.5)
Anti-viral medication
    Yes 103 (72)
    No 40 (28)
AST (IU/L) 29.7 (19.1)
ALT (IU/L) 29.8 (25.6)
Comorbidity
    Yes* 64 (55.2)
        HTN 9 (14.1)
        DM 12 (18.8)
        HL 5 (7.8)
        GB 29 (45.3)
        Others 21 (32.8)
    No 79 (44.8)
Table 1. Demographic and Clinical Characteristics. (N = 143). *Multiple responses. HTN, Hypertension; DM, 
Diabetes Mellitus; HL, Hyperlipidemia; GB, Gall bladder Disease; Others (G–I disease including gastric ulcer, 
duodenal ulcer).
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Correlations between Cortisol, Cytokines and Fatigue. Spearman correlation coefficients were used 
to examine the relationships of cortisol and cytokines (IL-6, TNF-α) with fatigue (Table 3). There was a signifi-
cant negative relationship between cortisol and fatigue (r = −0.172, p = 0.040). TNF-α and fatigue also showed a 
statistically significant positive correlation (r = 0.174, p = 0.038).
Quantile Regression and Multiple Linear Regressions for Fatigue. The results of quantile regression 
and multiple linear regression analyses for fatigue and the four sub-dimensions are presented in Table 4.
Results of Linear Regression. In the linear regression analysis, only TNF- α was determined to be a predic-
tor. Among the sub-dimensions, TNF- α also significantly influenced the Behavioral/Severity and Sensory 
dimensions.
Results of Quantile Regression. The estimated coefficients of selected variables from the quantile regression anal-
ysis are shown as percentiles of 0.1–0.9 (Fig. 1). In the quantile regression analysis, IL-6 was a significant predictor 
of total fatigue at the ninetieth percentile. TNF- α was also significant in the tenth percentile.
In the affective meaning and behavioral/severity dimensions, IL-6 was significant in the tenth percentile. TNF- 
α was significant at the 0.3 percentile in the behavioral/severity dimension. The effect of cortisol was significant at 
percentiles of 0.7, 0.8 and 0.9 in the cognitive/mood dimension. In addition, IL-6 was a significant predictor at the 
ninetieth percentile and TNF- α was significant at 0.1, 0.2, 0.3, 0.4, 0.5, 0.8 and 0.9. Lastly, in the sensory dimen-
sion, IL-6 was significant in the tenth percentile and TNF- α was significant at percentiles of 0.2 and 0.3 (Fig. 2).
Discussion
This is the first study to examine the relationship between fatigue, cortisol, and cytokines (IL-6 and TNF- α) 
among Koreans with HBV using quantile regression. We conducted quantile regression to identify the relation-
ships of cortisol, TNF- α, and IL-6 in accordance with the level of fatigue. There are two key findings of this study. 
First, cortisol, TNF- α, and IL-6 had significant correlations in our analysis of fatigue in Koreans with HBV. 
Total
Fatigue Group (Mean, SD) Statisticsa
Mild (n = 66) Moderate(n = 69) Sever (n = 8) X2 (p)
Cortisol 10.04 (4.52) 10.84 (4.45) 9.36 (4.55) 9.24 (4.16) 4.52 (0.104)
IL-6 2.15 (1.89) 1.97 (1.75) 2.30 (1.97) 2.36 (2.40) 1.79 (0.408)
TNFα 1.26 (1.31) 1.10 (0.79) 1.23 (0.85) 2.86 (4.36) 4.61 (0.100)
Table 2. Differences in Cortisol and Cytokines by Fatigue Group. (N = 143). aKruskal-Wallis test.
Cortisol IL-6b TNFαb
Fatigue −0.172* 0.174* 0.268**
Table 3. Correlations of Cortisol, Cytokines and Fatigue. (N = 143). bSpearman’s rho test. *p < 0.05, **p < 0.01.
Fatigue
Quantile Regression
OLS10% 20% 30% 40% 50% 60% 70% 80% 90%
Total
C −0.01 0.01 −0.06 −0.08 −0.09 −0.08 −0.06 −0.06 −0.07 −0.15
I 0.18 0.21* 0.12 0.05 0.02 −0.04 −0.06 −0.13 −0.25* 0.02
T 0.35* 0.31 0.28 0.27 0.26 0.25 0.22 0.25 0.20 0.25*
Affective Meaning
C −0.00 −0.01 −0.02 −0.07 −0.07 −0.04 −0.05 −0.05 −0.07 −0.08
I 0.13* 0.16 0.18 0.20 0.12 0.07 0.03 0.00 −0.15 0.08
T 0.16 0.27 0.22 0.13 0.11 0.11 0.08 0.05 0.22 0.12
Behavioral/Severity
C −0.02 −0.05 −0.04 −0.05 −0.08 −0.09 −0.10 −0.04 −0.10 −0.13
I 0.17* 0.14 0.06 −0.03 −0.08 −0.17 −0.26 −0.22 −0.14 −0.03
T 0.24 0.21 0.37* 0.36 0.32 0.32 0.68 0.37 0.69 0.24*
Cognitive/Mood
C 0.00 −0.03 −0.03 −0.00 −0.02 −0.06 −0.13* −0.13* −0.17* −0.15
I 0.10 0.13 0.11 0.17 0.16 0.04 −0.10 −0.18 −0.29* 0.02
T 0.53* 0.47* 0.45* 0.39* 0.34* 0.33 0.43 0.65* 0.71* 0.27*
Sensory
C −0.06 −0.03 −0.06 −0.06 −0.07 −0.06 −0.06 −0.02 −0.05 −0.14
I 0.17* 0.13 0.11 0.13 0.06 −0.06 −0.10 −0.03 −0.27 0.02
T 0.34 0.33* 0.29* 0.25 0.24 0.24 0.23 0.17 0.17 0.22*
Table 4. Quantile Regression and Multiple Linear Regression Analyses for Fatigue. (N = 143). C, Cortisol; I, 
Interleukin-6; TNFα, Tumor Necrosis Factor Alpha. *p < 0.05, **p < 0.01.
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Figure 1. (a) Cortisol and Total fatigue (b) IL-6 and Total fatigue (c) TNF- α and Total fatigue in Quantile 
Regression.
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Figure 2. (a) Cortisol and Cognitive/Mood of Fatigue (b) IL-6 and Cognitive/Mood of Fatigue (c) TNF- α and 
Cognitive/Mood of Fatigue in Quantile Regression.
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However, there were no differences in the cortisol, TNF- α, and IL-6 values between patients with different levels 
of fatigue in this study. Second, cortisol, TNF- α, and IL-6 were found to be predictors of fatigue in the quantile 
regression analysis, while TNF- α was only found to be a predictor in the linear regression analysis.
There were no differences in cortisol, TNF- α, and IL-6 between fatigue severity groups in this study. 
Meanwhile, decreased serum cortisol levels had a significant association with an increase in perceived fatigue. The 
negative correlation of fatigue and cortisol in this study is not consistent with the other studies targeting patients 
with severe fatigue. Previous studies have reported a positive correlation between fatigue and cortisol6,9,10. In 
other words, patients with higher levels of fatigue had higher levels of cortisol. Additionally, there were no differ-
ences of fatigue, cortisol, TNF- α, and IL-6 by taking anti-viral medication in this study. In Korea, the standard of 
administrating anti-viral medication is ≥2000 IU/ml of HBV-DNA in patients with HBV. Korean public medical 
insurance reimbursements are made according to this criteria and physicians prescribe anti-viral medication 
based on the standard15. Therefore, there might be no effect of taking anti-viral medication on fatigue because the 
participants may be well controlled HBV in this sample.
The characteristics of participants in this study were similar to patients with chronic fatigue syndrome who 
have mild to moderate levels of fatigue16. These symptoms, including the hypocortisolism of patients with chronic 
fatigue syndrome, are known to be due to chronic stress exposure and hypothalamic–pituitary–adrenal (HPA) 
axis dysfunction, even though the mechanism is unclear17. In the prior studies mentioned above, the stress expe-
rienced by the patient was relatively acute, such as stress induced by surgery, periodontitis, and less than one year 
of primary treatment for cancer, whereas the patients in our study had a mean duration of hepatitis 15.3 years or 
more. Thus, the chronicity of disease might explain the negative relationship between cortisol and fatigue seen in 
patients with chronic fatigue syndrome.
Another implication of the negative correlation pattern observed in chronic hepatitis B patients is that the 
longer the period of illness, the fewer physical symptoms may appear relative to the perceived fatigue of patient. 
Therefore, fatigue in HBV patients in a clinical setting seems to be interpreted more in the context of a subjective 
symptom than a physical symptom. The results of our quantile regression analysis support this in that cortisol was 
found to be a significant predictor only in the cognitive/mood dimension of fatigue. A study of the relationship 
between fatigue and cortisol in patients with coronary artery disease reported results similar to those in our study 
in that patients had lower cortisol levels as mental fatigue levels increased, unlike physical fatigue18. Therefore, it 
seems that the relationship between cortisol and fatigue might differ depending on the levels of fatigue in patients 
with HBV.
In addition, we compared the findings through OLS regression and quantile regression to identify the relation-
ships between fatigue, cortisol, and cytokines in patients with HBV. We found that TNF-α was only significantly 
correlated with overall fatigue but cortisol and IL-6 were not correlated in our linear regression analysis even 
though they were significantly correlated in Pearson correlation analysis. It seems that they were not explained as 
predictors because the correlation coefficient values of cortisol and IL-6 were low.
This result is consistent with the fatigue studies in cirrhotic liver transplant candidates, patients with acute 
myeloid leukemia, and healthy active individuals5,8,19, but not with studies in end-stage cancer patients or rheu-
matoid arthritis patients7,20. The findings of current study using the quantile regression method may provide 
clues to understanding the inconsistent results from previous studies on the relationship between fatigue and 
biomarkers. In our analysis, TNF- α did not show a trend correlating with fatigue and was not relevant in terms 
of overall fatigue. Cortisol and IL-6 also displayed the same pattern. However, with respect to the sub-dimensions 
of fatigue, cortisol and TNF- α showed a significant association with high levels of fatigue in the cognitive/mood 
dimension. The finding that the reliability of biomarkers depends on fatigue is consistent with the characteristics 
of perceive fatigue among Korean patients with HBV21. In other words, cortisol and TNF- α might explain the 
perceive fatigue in Korean patients with HBV. These findings support the notion that fatigue of Korean patients 
with HBV may relate to the cognitive/mood subdimension of fatigue rather than to physical fatigue.
Previous studies have used the linear regression method to determine the relationship between fatigue, corti-
sol, and TNF- α. The linear regression method presents a predictive value corresponding to the mean value of the 
dependent variable12,13. This method is likely to give inadequate results in analyzing variables that have various 
levels, such as fatigue. Since quantile regression is a suitable method for describing values in the lower or upper 
percentile of a distribution22, the method may be helpful in identifying variables that affect patients with high 
levels of fatigue that are most likely within this population to require intervention.
This study has some limitations. First, there was sampling bias in this study because of the use of self-reported 
data and it is not generalizable. Data collection was conducted from one university medical center. Second, the 
results of the current study are derived from a cross-sectional design. Therefore, it is necessary to be careful 
in interpreting the results, and a longitudinal analysis will be needed to obtain detailed information about the 
relationship between fatigue, cytokines, and cortisol. Third, this study was to examine the relationship between 
fatigue and IL-6 and TNF- α. The results may be limited to explain the relationship of fatigue and cytokine. 
Further studies need to confirm the relation of fatigue with several cytokines in patients with HBV.
Despite these limitations, this study provides significant findings for patients with HBV. Our study is the first 
study to analyze the physical parameters of patients with hepatitis B as they relate to fatigue. Also, the use of quan-
tile regression methods according to the level of fatigue has the methodological advantage of analyzing the full 
range of information as opposed to being limited to only the mean values of the data.
Conclusion
In this study, fatigue showed a significant negative correlation with cortisol in patients with HBV; however, a sig-
nificant positive correlation was seen with IL-6 and TNF-α. Cortisol, IL-6, and TNF- α were related to the levels 
of perceived fatigue, particularly in the cognitive/mood dimension in patients with HBV. The characteristic of 
fatigue in patients with chronic liver disease has been reported as a central fatigue. This type of fatigue is related 
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to psychological and behavioral aspects of patients with chronic disease23. Fatigue of patients with HBV also had 
a tendency to affecting psychological aspects in this study. To assess perceived fatigue with other psychological 
factors may be important to manage fatigue as well as to assess physical expression such as biomarkers relating 
fatigue in this population.
In addition, TNF- α was presented as a significant predictor of fatigue in both liner regression and quantile 
regression analysis in this study. To decrease TNF- α might have effect to manage fatigue, but TNF-α inhibitor 
is known as risk factor of reactivation in HBV24. Although TNF-a was significantly correlated with fatigue in 
this study, it should be careful to use anti- TNF-α therapy in fatigue management in patients with HBV. Further 
studies need to be conducted to find more evidences regarding effect of anti-TNF-α to relieve fatigue in patients 
with HBV.
The result of this study still has limited evidence to apply fatigue management for patients with HBV. However, 
this suggests that the fatigue patterns of patients with HBV are related to their mental and mood states and physi-
cal responses, such as cortisol and cytokine levels, are correlated with the nature of the fatigue. In the clinic, inter-
ventions to manage fatigue should be developed based on the characteristics of the fatigue in patients with HBV.
Methods
Design and Setting. This study was one part of the Fatigue study project targeting Korean patients with 
Hepatitis B (NRF-2011-0024717). This was a descriptive correlational study to determine the relationship 
between cortisol, cytokines (IL-6, TNF-α) and fatigue levels in 143 patients with Hepatitis B. Data was collected 
between March 2012 and October 2012 from the outpatient clinic of Severance Hospital, Yonsei University Health 
System in Seoul, Korea.
Sample and Sampling Criteria. This study was performed as a secondary data analysis on the Study 
of Fatigue related Hepatitis B reported in our previous study21. Participants were enrolled according to the 
following inclusion criteria: (1) patients aged 18 years and over, (2) patients diagnosed with HBV more than 
three months after the detection of HBsAg more than six months prior, (3) patients without liver cirrhosis, 
hepatocellular carcinoma, other infection or immune diseases, (4) patients able to give informed consent In 
this study, patients with interferon (IFN) therapy were not included. Over 95% of Koreans with HBV have HBV 
genotype C. It is known that IFN therapy is poor effect in HBV genotype C and IFN therapy is not standard 
therapeutic approach for Koreans with HBV25,26. Therefore, we excluded patients with IFN therapy in this 
study. The sample size was determined by G power analysis with an expected power of 0.80, significance level 
(a) of 0.05, and medium effect size (0.15). The sample size was calculated as 128 and ultimately 143 individuals 
participated in this study.
Ethical Consideration. This study was approved by Institutional Review Board at Severance Hospital, 
Yonsei University Health System (IRB # 4-2011-0746) and written consent was obtained from participants. After 
obtaining informed consent, individuals with HBV were enrolled in this study. Participants were asked personal 
data and perceived fatigue. Whole blood (10 ml) was collected from participants. The experimental methods were 
performed in accordance with the approved guidelines.
Measurements. Personal Data Questionnaire. Personal data was used to assess personal and clinical char-
acteristics. These data consisted of self-reported demographic characteristics on sex, age, length of diagnosis, 
status of taking anti-viral medication for HBV, and AST and ALT level were collected along with the personal data 
questionnaire. This document was developed by the investigators.
Fatigue. Fatigue was assessed using the Revised Piper Fatigue Scale (PFS)27. This is a 22-numerical item 
self-reported questionnaire assessing fatigue experienced at the present moment. The PFS contains four dimen-
sions of perceived fatigue: behavioral/severity, affective meaning, sensory, and cognitive. Scoring for each item 
ranges from zero to ten using a Likert scale. Severity of fatigue was scored as: none (0), mild (1–3), moderate 
(4–6), and severe (7–10) levels of fatigue. In this study, the investigators translated the questionnaire from English 
to Korean28. The reliability coefficient of the original scale was 0.97. In the present study, Cronbach α was 0.96.
Cortisol. Cortisol levels were analyzed using peripheral blood mononuclear cells (PMBCs) obtained from blood 
plasma sample drawn between 10 am and noon. From each participant, 10cc of peripheral blood was drawn for 
use in quantitatively measuring cortisol levels within serum using an Enzyme-Linked Immunosorbent Assay 
(ELISA).
Cytokine. Cytokine immunoassays tests were done in blood plasma sample. Detection of IL-6 and TNF-α in 
plasma were performed by ELISA.
Data Analysis. Analyses were conducted using SPSS version 21 for Windows (SPSS, 2013) and Stata ver-
sion 13.0 (Stata Corp, College Station, TX). Descriptive statistics were used to describe the characteristics of 
the samples. Spearman correlations were performed to examine the relationship between serum cytokines 
and perceived fatigue levels. Linear regression was used to identify predictors, which could affect fatigue level. 
Quantile regression analysis was used to measure the effect of cortisol and cytokines levels on the severity of 
fatigue. It estimates the relationship between a predictive variable and specific percentiles of the dependent 
variable (fatigue level).
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